baber/WOPTO huggingface dataset:
Patent NZ-579672-A (NZ)
Title: Laminated container seal with removal tab bound by adhesive
Inventor: THORSTENSEN-WOLL ROBERT WILLIAM
IPC: B65D51/20
Filed: 2008-02-19
Abstract: Disclosed is a sealing member for a container comprising: a heat actuated sealant or adhesive layer means for securing the sealing member to a container; a metal foil layer over and covering and adhesively bonded to the heat actuated sealant or adhesive layer means; a polyethylene or polypropylene foam or film layer over and covering and adhesively bonded to the foil layer; a first PET tab defining layer over and covering at least a portion of, but not adhesively bonded to at least part of that portion of, the polyethylene or polypropylene foam or film layer; a polypropylene film layer over and covering and adhesively bonded to both the portion of the polyethylene or polypropylene foam or film layer not covered by the first PET tab defining layer and also to the first PET tab defining layer itself, the bonds being established by an adhesive resin and catalyst chosen to provide a high bonding strength sufficient to hold against a manually generated force; and a second PET layer over and covering and adhesively bonded to the polypropylene film layer; whereby the first PET tab defining layer and the portions of the propylene film and second PET layers immediately above and adhesively bonded to the first PET tab defining layer serve as a tab to facilitate removal of the sealing member from a container to which it has been adhered.
Patent NZ-581837-A (NZ)
Title: Stoma seal coupling including stoma seal support
Inventor: NGUYEN-DEMARY TINH
IPC: A61F5/44
Filed: 2008-05-09
Abstract: A controlled evacuation ostomy appliance including: a) a pouch (10) including a first wall (12) and a second wall (14), the first wall including a first aperture (16) for receiving a stoma; b) a stoma seal (22) located at the first aperture and coupled to the second wall; and c) a stoma seal support (34, 36, 38) for supporting the stoma seal at the first aperture. The stoma seal support includes a member positioned inside the first aperture. Either: (i) the stoma seal support is coupled to the stoma seal to support the stoma seal directly; or (ii) the stoma seal support is coupled to the second wall, in order to support the stoma seal indirectly.
Patent NZ-583036-A (NZ)
Title: Method of treating a chamber having refractory walls
Inventor: DI LORETO OSVALDO
IPC: C04B41/87
Filed: 2008-07-03
Abstract: Discolsed is a method for treating a chamber having refractory walls, comprising: a spraying into said chamber, in the presence of oxygen, of a treatment composition comprising at least one organosilicone compound forming a majority portion by weight of said composition and - at least one hydrocarbon capable, in the presence of oxygen, of giving rise, at a first temperature, to an exothermic reaction, and a rise in temperature of said sprayed treatment composition to at least said first temperature, characterized in that the spraying in the presence of oxygen takes place in the closed chamber where the treatment composition, in a predominantly liquid state, is atomized in the form of suspended particles, and in that the method further comprises during said exothermic reaction, a decomposition of said at least one organosilicon compound with formation of a colloidal silica aerosol in the closed chamber and the establishment of an overpressure therein, and a spreading of a colloidal silica layer on the refractory walls of said chamber with, following said overpressure, penetration of the colloidal silica into the microcracks of the refractory walls. The method could comprise a further step of raising the temperature to a second temperature which is higher than the fist temperature. The organosilicon could be chosen from silicones, siloxanes, organosilicates and siloxysilicates. The hydrocarbon could by chosen from aliphatic or aromatic hydrocarbons especially hexane, cyclohexane, heptane, benzene, toluene, xylene and mixtures thereof. Also disclosed is the use of the composition for treating the refractory walls of a chamber by spraying said composition into said chamber in the presence of oxygen.
Patent NZ-583092-A (NZ)
Title: Thin cast steel strip with a manganese to sulphur ratio intended to reduce microcracking
Inventor: SOSINSKY DAVID J
IPC: B22D11/06
Filed: 2008-08-12
Abstract: 583092 Disclosed is a thin cast steel strip and method of making thereof with improved resistance to microcracking. The steel strip is produced by continuous casting and contains a carbon content between about 0.010% and about 0.065% by weight, less than 5.0% by weight chromium, at least 70 ppm of total oxygen and between 20 and 70 ppm of free oxygen, and manganese to sulfur ratio greater than about 250:1. The carbon content in the cast strip may be below 0.035%, less than 0.005% by weight titanium, and the average manganese to silicon ratio in the strip produced may be greater than 3.5:1. The carbon content may be less than 0.035%, the casting speed less than 76.68 meters per minute, and the tundish temperature of the molten metal is maintained below 1612 DEGREE C (2933.7 DEGREE F).
Patent NZ-586490-A (NZ)
Title: Method of coating a steel strip with a mixture of metals to increase ductility
Inventor: SCOTT ROBERT IAN
IPC: C23C2/40
Filed: 2009-02-06
Abstract: Disclosed is a method of forming a coating of an Al-Zn-Si-Mg alloy on a steel strip. The steel strip is passed through a hot dip coating bath that contains AI, Zn, Si, and Mg and optionally other elements to form an alloy coating on the strip. The coated strip is then heat treated at a hold temperature of at least 150°C to improve the ductility of the coating. The hold temperature is a maximum temperature that the strip is maintained at during the heat treating process.
Patent NZ-588015-A (NZ)
Title: Process for isolating sialic acid containing oligosaccharides, and the compositions containing sialic acid containing oligosaccharides obtainable thereby
Inventor: BONTE ALFRED WILLY
IPC: A23L33/00
Filed: 2009-03-13
Abstract: Disclosed is a process for isolating sialic acid containing carbohydrates such as sialyllactose from a defatted milk stream by subjecting the milk stream to an anion exchange step utilizing an anion exchange resin in the free base form, having a moisture content of 30-48%; followed by performing an anion exchange step.
Patent NZ-592399-A (NZ)
Title: Vertical junction field effect transistors having sloped sidewalls and methods of making
Inventor: SHERIDAN DAVID C
IPC: H01L21/336
Filed: 2009-11-05
Abstract: 592399 Disclosed is a semiconductor device. The device includes a substrate of a semiconductor material of a first conductivity type and a channel layer above an upper surface of the substrate. The channel layer has two or more raised regions, each extending upward from adjacent channel layer surfaces such that the raised regions each have an upper surface and first and second sidewalls. The first and second sidewalls of each of the raised regions in the vicinity of the adjacent channel layer surfaces taper inward from vertical to form an angle of at least 5° from vertical to the upper surface of the substrate. In the vicinity of the upper surface of the respective raised region, the first and second sidewalls taper inward at an angle of <50 from vertical to the upper surface of the substrate. Each of the raised regions includes an inner portion of a semiconductor material of a first conductivity type, and outer portions of a material of a second conductivity type different from the first conductivity type. The outer portions are beneath the first and second sidewalls. Gate regions of material of the second conductivity type lie beneath the adjacent channel layer surfaces and contiguous with the outer portions of the raised regions. A source layer of a material of the first conductivity type lies above each of the upper surfaces of the raised regions.
Patent NZ-592432-A (NZ)
Title: Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1)
Inventor: TREMBLAY GILLES BERNARD
IPC: A61K39/00
Filed: 2009-11-03
Abstract: 592432 Disclosed are isolated antibodies or antigen binding fragments thereof which are capable of specific binding to kidney associated antigen 1 (KAAG1) as defined herein.
Patent NZ-592908-A (NZ)
Title: Audio-enabled energy meter devices and methods
Inventor: VADALI MANOJ KUMAR
IPC: G01R11/63
Filed: 2011-05-17
Abstract: Devices and methods for generating audio alerts while monitoring power consumption of a load are disclosed. In one embodiment an audio-enabled energy meter includes metering circuitry, communication circuitry and a processor. The metering circuitry monitors (72) the power consumption of a load. The communication circuitry obtains account information from a power utility associated with the load. The processor generates a speech audio alert (78) based at least in part on the power consumption of the load and the account information.
Patent NZ-595212-A (NZ)
Title: Liposome composition
Inventor: KIKUCHI HIROSHI
IPC: A61K9/127
Filed: 2010-03-30
Abstract: 595212 Disclosed is a liposome composition which contains eribulin or a pharmacologically acceptable salt thereof. The liposome composition further comprises a liposome internal phase comprising an ammonium salt and at least one component selected from sodium hydroxide, ammonium water, hydrochloric acid, acetic acid, lactic acid, tartaric acid, succinic acid, citric acid and phosphoric acid. Additionally disclosed are methods of preparing the liposome compositions.
Patent NZ-599825-A (NZ)
Title: Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
Inventor: ZHANG XIAOKUI
IPC: A61K35/12
Filed: 2008-09-29
Abstract: Discloses the use of human placental perfusate cells in the manufacture of a medicament for suppressing the proliferation of blood cancer cells, wherein the placental perfusate cells are (a) total nucleated cells from placental perfusate, (b) placental perfusate cells that have been treated to remove at least one type of cell, or (c) placental perfusate cells that have been treated to enrich for at least one type of cell. and wherein the placental perfusate cells are contacted with an immunomodulatory compound to exhibit detectable more cytotoxicity towards solid tumor cells than an equivalent number of perfusate cells that have not been contacted with an immunomodulatory compound.
Patent NZ-601126-A (NZ)
Title: Voltage-gated sodium channel blockers
Inventor: LIN GUOLIANG
IPC: C07D295/04
Filed: 2011-01-13
Abstract: Disclosed is a pyridine and phenyl substituted piperazine compound of formula (IV) where the substituents are as disclosed in the specification. Examples of compounds of formula (IV) include: 1-[(4-{ [[(2-Chloro-6-fluorophenyl)methyl](ethyl)ammonio]methyl} phenyl)methyl]-4-(3-{ [(1-methylethyl)oxy]carbonyl} -2-pyridinyl)piperazin-1-ium dimaleate; 1-methylethyl2-{ 4-[(4-{ [[(2-chloro-6-fluorophenyl)methyl](ethyl)amino]methyl} phenyl)methyl]-1-piperazinyl} -3-pyrid inecarboxylate; bis(1-methylethyl)2,2’-{ benzene-1,4-diylbis[methanediyl(ethylimino)(3S)-3,1-pyrrolidinediyl]} di(3-pyridinecarboxylate). Also disclosed is a composition comprising a compound of formula (IV) and the use of a compound of formula (IV) in the manufacture of a medicament for treating respiratory or respiratory tract diseases such as cystic fibrosis, bronchitis, chronic bronchitis, chronic obstructive pulmonary disease (COPD) and cough.
Patent NZ-602229-A (NZ)
Title: Kit, composition, product or medicament for treating cognitive impairment
Inventor: YAMAGUCHI YOSHIMASA
IPC: A61K31/4184
Filed: 2009-02-28
Abstract: Disclosed is a use of a combination of donepezil hydrochloride, rivastigmine tartrate, galantamine hydrobromide, or memantine hydrochloride and a heterocyclic compound which is preferably selected from spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2’-indan], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2’-(4’-fluoroindan)], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2’-(5’-methoxyindan)], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2’-(4’-cyanoindan)], spiro[imidazo[1,2-a]pyridin-2(3H)-one-3,2’-(4’-hydroxyindan)], and spiro[8-hydroxy-imidazo[1,2-a]pyridin-2(3H)-one-3,2’-indan] for the manufacture of a medicament for treating cognitive impairment selected from cerebrovascular disease, Lewy body dementia, Alzheimer’s disease, Parkinson’s disease, Pick’s disease, Huntington’s disease or Down’s syndrome, memory impairment due to aging.
Patent NZ-602945-A (NZ)
Title: Novel adjuvant compositions
Inventor: BAGI CEDO MARTIN
IPC: A61K39/00
Filed: 2009-06-24
Abstract: NZ 602945 Disclosed is an immunogenic composition comprising an adjuvant formulation and an immunologically effective amount of an antigen component, wherein the adjuvant formulation comprises a saponin, a sterol, a quaternary ammonium compound, a polyacrylic acid and a glycolipid. Also disclosed is its method of preparation and use in medical treatments.
Patent NZ-607258-A (NZ)
Title: Child-resistant and senior-friendly eco-friendly pill dispenser blister package
Inventor: WESTON MICHAEL H
IPC: B65D83/04
Filed: 2011-07-18
Abstract: 607258 A blister and package system made of a blister card and an outer package with interacting locking mechanisms. The blister card or strip is inserted into the outer package or sleeve and locks the card or strip inside the package. The user is able to expose the blisters from the outer package by disengaging the lock. The packaging system has an insert with a locking member attached thereto. A top panel (504), bottom panel, and first inside panel (502), when folded, form a sleeve that is open at a first end and closed at a second end, and the first inside panel comprises a first cut-out (528) proximate to the closed second end. The sleeve and the insert are adapted to allow the insert to slide within the sleeve along a sliding direction between the first open end and the closed second end. The first cut-out (528) forms a first lip on the first inside panel to receive the locking member when the insert is positioned within the sleeve.
Patent NZ-611131-A (NZ)
Title: Lens with tir for off-axial light distribution
Inventor: CASTILLO MARIO A
IPC: F21V5/04
Filed: 2009-05-22
Abstract: Disclosed is a total internal reflection (TIR) lens for directing light from a LED emitter in a preferential-side off-axial direction with respect to an emitter axis that extends through a centre of the emitter. The lens includes an emitter-adjacent base end which forms a light-receiving opening, an inner surface extending from the base end and forming a void, an output-end surface configured to direct light toward the preferential side and with a recess on the non-preferential side with a portion of the output-end surface extending from the recess across the emitter axis to an output-end-surface edge on the preferential side, and an outer lateral surface configured for TIR (total internal reflection) to direct light toward the output-end surface. The inner surface includes a surrounding lateral surface formed about the emitter axis and an end surface configured to direct light toward the preferential side. The surrounding lateral surface is preferably a substantially cylindrical surface, and most preferably has a right cylindrical shape of substantially circular cross-section. The light from the emitter exits the output-surface predominantly toward the preferential side.
Patent NZ-611144-A (NZ)
Title: Multi-resolution graphical display for feedback on chest compression depth
Inventor: NOVA RICHARD C
IPC: G06F19/00
Filed: 2011-11-29
Abstract: Disclosed is a medical device including a display (160) for providing feedback to a rescuer (120) who is performing Cardio Pulmonary Resuscitation (CPR) chest compressions to a patient (130). The display (160) is structured to graphically indicate an instantaneous value of a measured compression depth of the chest of the patient (130). The display (160) includes an indicator range (170) that corresponds at least in part to a compression depth range of some of the measured compression depths and an indicator (162) represented as progressing along the indicator range (170) as the depth changes within the compression depth range (170) to represent a value of the measured compression depth in relation to the indicator range (170). When the measured compression depth is passing a first point (demarcating first portion of indicator range 172) of the compression depth range (170), the indicator (162) progresses at a first rate relative to a first difference in the measured compression depth, and when the measured compression depth is passing a second point of the compression depth range (170) that is distinct from the first point, the indicator (162) progresses at a second rate that is different from the first rate relative to the first difference in the measured compression depth.
Patent NZ-614904-A (NZ)
Title: Mlk inhibitors and methods of use
Inventor: GELBARD HARRIS A
IPC: C07D487/14
Filed: 2009-11-25
Abstract: Disclosed are compounds of formula (I) having an inhibitory effect on Mixed Lineage Kinases (MLK). Also provided are pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by Mixed Lineage Kinase inhibition. Also provided are methods of treatment of neuropsychiatric disorders which comprise the inhibition of Mixed Lineage Kinases. Examples of compounds of formula (I) are: 2-phenyl-N-{ 4-[5-(3,4,5-trimethoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzyl} -acetamide and 3-phenyl-N-{ 4-[5-(3,4,5-trimethoxy-phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-benzyl} -propionamide.
Patent NZ-619746-A (NZ)
Title: Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
Inventor: WALLACE DAVID -
IPC: A23L23/00
Filed: 2004-08-06
Abstract: 619746 Disclosed is a caboxamide substituted heterocycle of formula (I) where the heterocycle is pyrrol, pyrazole, thiazole, oxazole, isoxazol, isothiazole, thiophene, pyrazine or pyrimidine; R2 is an optionally substituted branched alkyl or cycloalkyl and the rest of the substituents are as disclosed in the specification. An examples of a compound of formula (I) is: 4,5-Dichloro-isothiazole-3-carboxylic acid (2-methylcyclohexyl)-amide. The compounds are useful as food additives, flavour or taste modifiers, such as a flavouring or flavouring agents and flavour or taste enhancers, more particularly savoury (”umami”) or sweet taste modifiers, - savoury or sweet flavouring agents and savoury or sweet flavour enhancers, for foods, beverages, and other comestible or orally administered medicinal products or compositions.
Patent NZ-620848-A (NZ)
Title: Thermal energy storage apparatus
Inventor: PARKINSON NEIL
IPC: F28D20/02
Filed: 2012-08-09
Abstract: Thermal energy storage apparatus (10), containment vessel for phase change material, and method of construction of vessel. The apparatus includes a block (12) of a heat-absorbing material. The block (12) is a contiguous block of heat-absorbing material having a plurality of holes (14). Heat storage elements are seated within each of the holes (14) and is in thermal contact with the block (12). Each heat storage element includes a phase change material, in this case silicon metalloid, stored in a containment vessel. The containment vessel has a substantially cylindrical sidewall with an inner surface that tapers inwardly from a first end to a second end. This when the phase change material undergoes a phase change the material will preferentially expand in the direction of the first end due to the relatively greater thickness of the sidewall.
Patent NZ-621517-A (NZ)
Title: Method to remove microorganisms on plant material
Inventor: GIORGIO MARIANO BALESTRA
IPC: A61L2/20
Filed: 2014-02-25
Abstract: A method for eliminating the microbial load of the bacterial cells of Pseudomonas sryringae pv. actinidiae (PSA), said method involving an antibacterial treatment of Actinidia spp pollen in two successive phases: in the first, a plant sample is subjected to heating; in the second, the same sample is subjected to ozone.
Patent NZ-703163-A (NZ)
Title: Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
Inventor: FINKIELSZTEIN SERGIO
IPC: A61K31/70
Filed: 2011-04-15
Abstract: Disclosed is the use of a composition comprising shortened fibres of poly-β-1→4-Nacetylglucosamine (“sNAG nanofibres”) in the manufacture of a medicament for treating an intestinal disease or a condition associated with a bacterial imbalance in a subject in need thereof, wherein the medicament is manufactured to be topically administered, wherein the sNAG nanofibres are less than 10 μm in average length, wherein the sNAG nanofibres comprise 70% or more than 70% of the N-acetylglucosamine monosaccharides, and wherein the sNAG nanofibres do not have an effect, or substantially have no effect, on bacterial growth or survival of Staphylococcus aureus bacterial cultures in vitro.
Patent NZ-704191-A (NZ)
Title: Cell-penetrating peptides and uses therof
Inventor: HAAS ALEXANDER
IPC: C07K14/00
Filed: 2011-06-14
Abstract: Discloses a peptide attached to one or more nucleic acid molecules capable of being internalized into a cell, wherein the peptide molecule a) has a the sequence IREIMEKFGKQPVSLPARRLKLRGRKRRQR (SEQ ID NO: 3); which is internalized into a cell with an efficacy being at least 200% of the internalization efficacy of the TAT peptide having the amino acid sequence GRKKRRQRRRPPQ (SEQ ID NO: 1) and wherein the attachment is accomplished by a linkage selected from the group consisting of a covalent linkage and a non-covalent linkage.
Patent NZ-716172-A (NZ)
Title: A misting apparatus and dust suppression system employing the same
Inventor: PELLIZZARI ANDREW MARK
IPC: E21F5/04
Filed: 2014-07-25
Abstract: The loading and unloading of ships with dusting materials creates a significant amount of dust. Depending on the nature of the material, this dust is at least messy and therefore undesirable, and at worst dangerous. Solutions for this problem have been previously proposed, which involved misting the space above the material, however some dust would still become airborne and escape the container. The present disclosure relates to a misting apparatus. In one form, the misting apparatus comprises a fan, a turbine comprising at least one rotor assembly, a fluid emitter issuing a jet of a fluid to drive the rotating assembly via the rotor assembly, the fluid emitter being so positioned with respect to the fan as to issue the jet of fluid into the airflow generated by the fan to form a mist that is carried by the airflow, and with a further means for introducing the fluid to the airflow.
Patent NZ-740551-A (NZ)
Title: Fcv recombinant vaccines and uses thereof
Inventor: POULET HERVE
IPC: C12N15/866
Filed: 2016-08-16
Abstract: The present invention encompasses FCV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FCV antigens. The invention also encompasses recombinant vectors encoding and expressing FCV antigens, epitopes or immunogens which can be used to protect animals against FCV infection. The invention further encompasses vaccines comprising FCV capsid protein from strain 100869 that forms FCV empty capsids or FCV VLPs, wherein the vaccine is not adjuvanted.
Patent NZ-754492-A (NZ)
Title: Compositions and methods of use of phorbol esters
Inventor: CHANG RICHARD L
IPC: A61P31/18
Filed: 2008-01-30
Abstract: Disclosed is the use of phorbol esters of Formula I, including 12-O-tetradecanoylphorbol-13-acetate (TPA / phorbol-12-myristate-13-acetate / PMA), for the treatment of HIV/AIDS or neoplasms. In a preferred embodiment the phorbol esters of Formula I are for reducing or controlling resistance to anti-retroviral therapy in an HIV infected mammalian subject with said resistance.